Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen
Anti-PM/Scl antibodies represent a specific serological marker for a subset of patients with scleroderma (Scl) and polymyositis (PM), and especially with the PM/Scl overlap syndrome (PM/Scl). Anti-PM/Scl reactivity is found in 24% of PM/Scl patients and is found in 3–10% of Scl and PM patients. The...
Main Authors: | Mahler, Michael, Raijmakers, Reinout, Dähnrich, Cornelia, Blüthner, Martin, Fritzler, Marvin J |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2005
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174964/ |
Similar Items
-
Autoantibodies directed to novel components of the PM/Scl complex, the human exosome
by: Brouwer, Rick, et al.
Published: (2002) -
Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies
by: Mahler, Michael, et al.
Published: (2005) -
Caspase-mediated cleavage of the exosome subunit PM/Scl-75 during apoptosis
by: Schilders, Geurt, et al.
Published: (2007) -
Autoantibodies in Systemic Autoimmune Disorders
by: Mahler, Michael, et al.
Published: (2014) -
Current Concepts and Future Directions for the Assessment of Autoantibodies to Cellular Antigens Referred to as Anti-Nuclear Antibodies
by: Mahler, Michael, et al.
Published: (2014)